Ep. 61: Simon Erickson: Discover Power Growth Stocks With These Key Metrics
Investing With IBD
00:00
Roche's Acquisition of Foundation Medicine and Foundation Medicine Improves Cancer Survival Rates
Roche Holdings is a drug maker but the thing that actually attracts me about Roche was an acquisition they made two years ago of a company called Foundation Medicine and Foundation Medicine what they were doing was characterizing cancerous tumors. Things like this are improving the outcomes for health care and there's nowhere in health care that's more important than oncology where we've gotten used to stage three or four cancer.
Transcript
Play full episode
